Evidence map›Paper›PMID 34082820›Full record

ArticleCell & bioscience2021

A ribonucleoprotein transfection strategy for CRISPR/Cas9-mediated gene editing and single cell cloning in rainbow trout cells.

Marina Zoppo, Nicole Okoniewski, Stanislav Pantelyushin, Johannes Vom Berg, Kristin Schirmer

Open access · goldAbstract read
In one paragraph

Article in Cell & bioscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Efficient Gene Editing in Fish Primary Germline Stem Cells.International journal of molecular sciences · 2026
    Article
  2. Advances in Fish Gene Editing.Animals : an open access journal from MDPI · 2026
    Review
  3. Article
  4. Animals : an open access journal from MDPI · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Marina ZoppoEawag, Swiss Federal Institute of Aquatic Science and Technology, 8600, Dübendorf, Switzerland. marina.zoppo@eawag.ch.ORCID http://orcid.org/0000-0001-6506-5719
Nicole OkoniewskiEawag, Swiss Federal Institute of Aquatic Science and Technology, 8600, Dübendorf, Switzerland.
Stanislav PantelyushinInstitute of Laboratory Animal Science, University of Zurich, 8952, Schlieren, Switzerland.ORCID https://orcid.org/0000-0002-3490-3860
Johannes Vom BergInstitute of Laboratory Animal Science, University of Zurich, 8952, Schlieren, Switzerland.ORCID https://orcid.org/0000-0002-4086-1564
Kristin SchirmerEawag, Swiss Federal Institute of Aquatic Science and Technology, 8600, Dübendorf, Switzerland.ORCID https://orcid.org/0000-0003-1116-4724
Swiss Federal Institute of Aquatic Science and Technology · CHUniversity of Zurich · CHETH Zurich · CH

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CH) CRSK-3-190920
6 · The paper itself

Abstract

backgroundThe advent of the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 technology marked the beginning of a new era in the field of molecular biology, allowing the efficient and precise creation of targeted mutations in the genome of every living cell. Since its discovery, different gene editing approaches based on the CRISPR/Cas9 technology have been widely established in mammalian cell lines, while limited knowledge is available on genetic manipulation in fish cell lines. In this work, we developed a strategy to CRISPR/Cas9 gene edit rainbow trout (Oncorhynchus mykiss) cell lines and to generate single cell clone-derived knock-out cell lines, focusing on the phase I biotransformation enzyme encoding gene, cyp1a1, and on the intestinal cell line, RTgutGC, as example.

resultsRibonucleoprotein (RNP) complexes, consisting of the Cas9 protein and a fluorescently labeled crRNA/tracrRNA duplex targeting the cyp1a1 gene, were delivered via electroporation. A T7 endonuclease I (T7EI) assay was performed on flow cytometry enriched transfected cells in order to detect CRISPR-mediated targeted mutations in the cyp1a1 locus, revealing an overall gene editing efficiency of 39%. Sanger sequencing coupled with bioinformatic analysis led to the detection of multiple insertions and deletions of variable lengths in the cyp1a1 region directed by CRISPR/Cas9 machinery. Clonal isolation based on the use of cloning cylinders was applied, allowing to overcome the genetic heterogeneity created by the CRISPR/Cas9 gene editing. Using this method, two monoclonal CRISPR edited rainbow trout cell lines were established for the first time. Sequencing analysis of the mutant clones confirmed the disruption of the cyp1a1 gene open reading frame through the insertion of 101 or 1 base pair, respectively.

conclusionsThe designed RNP-based CRISPR/Cas9 approach, starting from overcoming limitations of transfection to achieving a clonal cell line, sets the stage for exploiting permanent gene editing in rainbow trout, and potentially other fish cells, for unprecedented exploration of gene function.

Indexed as

CRISPR/Cas9Cytochrome P450Rainbow trout (Oncorhynchus mykiss)Ribonucleoprotein (RNP) complexRTgutGC

Identifiers

PMID34082820
PMCPMC8176604
OpenAlexW3165077654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.